197 related articles for article (PubMed ID: 34495453)
1. Regulating pediatric off-label uses of medicines in the EU and USA: challenges and potential solutions : Comparative regulation framework of off label prescriptions in pediatrics: a review.
Guidi B; Parziale A; Nocco L; Maiese A; La Russa R; Di Paolo M; Turillazzi E
Int J Clin Pharm; 2022 Feb; 44(1):264-269. PubMed ID: 34495453
[TBL] [Abstract][Full Text] [Related]
2. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
[TBL] [Abstract][Full Text] [Related]
3. Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study.
Pratico AD; Longo L; Mansueto S; Gozzo L; Barberi I; Tiralongo V; Salvo V; Falsaperla R; Vitaliti G; La Rosa M; Leonardi S; Rotondo A; Avola N; Sgarlata D; Damiano A; Tirantello M; Anzelmo G; Cipolla D; Rizzo A; Russo A; Ruggieri M; Salomone S; Drago F
Curr Drug Saf; 2018; 13(3):200-207. PubMed ID: 29921210
[TBL] [Abstract][Full Text] [Related]
4. [Off-label and unlicensed drug use: Results from a pilot study in a pediatric intensive care unit].
García-López I; Fuentes-Ríos JE; Manrique-Rodríguez S; M Fernández-Llamazares C
An Pediatr (Barc); 2017 Jan; 86(1):28-36. PubMed ID: 27151379
[TBL] [Abstract][Full Text] [Related]
5. [Off-label pediatric medicines in Spain].
Piñeiro Pérez R; Núñez Cuadros E; Rodríguez Marrodán B; Escrig Fernández R; Gil Lemus MÁ; Manzano Blanco S; Calvo C
An Pediatr (Engl Ed); 2021 Mar; 94(3):188.e1-188.e9. PubMed ID: 33509731
[TBL] [Abstract][Full Text] [Related]
6. Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation.
Lindell-Osuagwu L; Hakkarainen M; Sepponen K; Vainio K; Naaranlahti T; Kokki H
J Clin Pharm Ther; 2014 Apr; 39(2):144-53. PubMed ID: 24329556
[TBL] [Abstract][Full Text] [Related]
7. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
[TBL] [Abstract][Full Text] [Related]
8. Is off-label use a risk factor for adverse drug reactions in pediatric patients? A prospective study in an Indian tertiary care hospital.
Saiyed MM; Lalwani T; Rana D
Int J Risk Saf Med; 2015; 27(1):45-53. PubMed ID: 25766066
[TBL] [Abstract][Full Text] [Related]
9. Pharmacoepidemiological evaluation of off label and unlicensed prescription in pediatric intensive care units at tertiary care hospitals of Peshawar, Pakistan.
Aamir M; Abid Shah M; Naheed Kauser T; Khan N; Mehmood I; Ali Khan J; Iqbal W
Pak J Pharm Sci; 2023 Jan; 36(1):81-87. PubMed ID: 36967500
[TBL] [Abstract][Full Text] [Related]
10. Unlicensed and off-label use of medicines in children admitted to the intensive care units of a hospital in Malaysia.
Lee JL; Redzuan AM; Shah NM
Int J Clin Pharm; 2013 Dec; 35(6):1025-9. PubMed ID: 24022725
[TBL] [Abstract][Full Text] [Related]
11. Extent, reasons and consequences of off-labeled and unlicensed drug prescription in hospitalized children: a narrative review.
Shuib W; Wu XY; Xiao F
World J Pediatr; 2021 Aug; 17(4):341-354. PubMed ID: 34080130
[TBL] [Abstract][Full Text] [Related]
12. Comparative Assessment of Off-label and Unlicensed Drug Prescriptions in Children: FDA Versus ANSM Guidelines.
Berdkan S; Rabbaa L; Hajj A; Eid B; Jabbour H; Osta NE; Karam L; Khabbaz LR
Clin Ther; 2016 Aug; 38(8):1833-44. PubMed ID: 27392716
[TBL] [Abstract][Full Text] [Related]
13. Serious Adverse Events Associated with Off-Label Use of Azithromycin or Fentanyl in Children in Intensive Care Units: A Retrospective Chart Review.
Oshikoya KA; Wharton GT; Avant D; Van Driest SL; Fenn NE; Lardieri A; Doe E; Sood BG; Taketomo C; Lieu P; Yen L; McMahon AW
Paediatr Drugs; 2019 Feb; 21(1):47-58. PubMed ID: 30484072
[TBL] [Abstract][Full Text] [Related]
14. Systematic Data Monitoring and Analysis of Cardiovascular Off-label Prescriptions in Pediatrics: Focus on Angiotensin-Converting Enzyme Inhibitors (ACE-I) and Beta Blockers.
Cammarata SM; Capone G; Lombardi N; Pani L; Mugelli A
High Blood Press Cardiovasc Prev; 2022 Mar; 29(2):169-195. PubMed ID: 34997917
[TBL] [Abstract][Full Text] [Related]
15. Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety.
Cuzzolin L; Atzei A; Fanos V
Expert Opin Drug Saf; 2006 Sep; 5(5):703-18. PubMed ID: 16907660
[TBL] [Abstract][Full Text] [Related]
16. Pediatric off-label drug use in China: risk factors and management strategies.
Zhang L; Li Y; Liu Y; Zeng L; Hu D; Huang L; Chen M; Lv J; Yang C
J Evid Based Med; 2013 Feb; 6(1):4-18. PubMed ID: 23557523
[TBL] [Abstract][Full Text] [Related]
17. Drug utilization and off-label drug use in Spanish pediatric gastroenterology outpatients.
Ruíz-Antorán B; Piñeiro R; Avendaño C; Román E; Cilleruelo ML; Gutiérrez-Junquera C; Centeno G; Cilleruelo MJ
J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):173-7. PubMed ID: 23328455
[TBL] [Abstract][Full Text] [Related]
18. [Frequency of prescriptions of off-label drugs and drugs not approved for pediatric use in primary health care in a southern municipality of Brazil].
Gonçalves MG; Heineck I
Rev Paul Pediatr; 2016; 34(1):11-7. PubMed ID: 26530249
[TBL] [Abstract][Full Text] [Related]
19. Prescribing of medicines in the Danish paediatric population outwith the licensed age group: characteristics of adverse drug reactions.
Aagaard L; Hansen EH
Br J Clin Pharmacol; 2011 May; 71(5):751-7. PubMed ID: 21241353
[TBL] [Abstract][Full Text] [Related]
20. Healthcare professional experiences and attitudes on unlicensed/off-label paediatric prescribing and paediatric clinical trials.
Mukattash T; Hawwa AF; Trew K; McElnay JC
Eur J Clin Pharmacol; 2011 May; 67(5):449-61. PubMed ID: 21243345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
